Dresden, Germany
anvajo, headquartered in Germany, emerged from the Technical University of Dresden in 2016 as an innovative force in the MedTech sector. With a mission to deliver "Lab diagnostics for everyone, everywhere," anvajo combines its proprietary technologies—advanced optics, digital holography, microfluidics, spectroscopy, and AI-driven data analytics—to create portable diagnostic systems. These systems provide real-time, lab-quality results directly at the point of care, moving away from centralized laboratory dependence.
At the heart of anvajo's strategy lies a scalable platform concept. Instead of isolating devices, the company offers technology building blocks for partners across human health, veterinary medicine, and life sciences to develop next-gen diagnostic solutions. This model not only enhances diagnostic accessibility but also optimizes healthcare systems by reducing turnaround times and streamlining processes.
The company recently secured a seed investment on 01 December 2024 from Bold Ventures, Mina, MEDEVICE Capital, FSF Beteiligungs, Die BrückenKöpfe, and JVL Ventures. As anvajo continues to collaborate with global leaders, its vision of democratizing diagnostics aligns well with growing demands for accessible healthcare solutions.
